Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on December 5, 2005

Hypertension. 2005
Published online before print December 5, 2005, doi: 10.1161/01.HYP.0000196272.79321.11
A more recent version of this article appeared on January 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
47/1/122    most recent
01.HYP.0000196272.79321.11v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brassard, P.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brassard, P.
Right arrow Articles by Schiffrin, E. L.
Related Collections
Right arrow Remodeling
Right arrow ACE/Angiotension receptors

Submitted on August 24, 2005
Revised on September 8, 2005

Role of Angiotensin Type-1 and Angiotensin Type-2 Receptors in the Expression of Vascular Integrins in Angiotensin II-Infused Rats

Pascal Brassard; Farhad Amiri; Gaétan Thibault; and Ernesto L. Schiffrin*

From the Experimental Hypertension Laboratory (P.B., F.A., E.L.S.) and Laboratory of Cellular Biology of Hypertension (G.T.), Canadian Institutes of Health Research Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, Montreal, Quebec, Canada.

* To whom correspondence should be addressed. E-mail: ernesto.schiffrin{at}ircm.qc.ca.

Abstract--Angiotensin II plays an important role in vascular remodeling through effects that involve, in part, interactions of vascular smooth muscle cells with extracellular matrix via integrins, which belong to a family of transmembrane receptors. We hypothesized that angiotensin (Ang) II regulates expression of vascular integrins and their ligands in experimental hypertension. Rats were infused subcutaneously with Ang II and received angiotensin type-1 (AT1) receptor blocker losartan, the AT1/angiotensin type-2 (AT2) [Sar1-Ile8]-Ang II, or the vasodilator hydralazine for 7 days. Osteopontin and integrin subunit expression were evaluated immunohistochemically. Ang II enhanced vascular {alpha}8, {beta}1, {beta}3 integrins and osteopontin expression, which were significantly reduced by losartan, [Sar1-Ile8]-Ang II, and hydralazine. Although Ang II increased vascular {alpha}5 subunit expression, this was additionally increased by losartan. Losartan was the only treatment that induced {alpha}1 subunit expression. These results demonstrate that AT1 and AT2 receptors have countervailing effects on vascular integrin subunit expression that may influence their effects on vascular remodeling and extracellular matrix composition.


Key words: renin-angiotensin system • aorta • extracellular matrix • hypertension • osteopontin




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Louis, A. Kakou, V. Regnault, C. Labat, A. Bressenot, J. Gao-Li, H. Gardner, S. N. Thornton, P. Challande, Z. Li, et al.
Role of {alpha}1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2597 - H2604.
[Abstract] [Full Text] [PDF]